ACT's technology accurately predicts tissue temperature, lesion volume, and lesion depth in the heart – in real time. Using a proprietary chip technology that delivers real time non-invasive in-tissue temperature readings, physicians now, for the first time, can predict lesion depth and transmurality in irrigated cardiac ablation procedures.